Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 5Phase 3 2Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 10Rectal Neoplasms 3Stomach Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Colonic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Margins of Excision 1Colorectal Cancer Metastatic 1Carcinoma, Neuroendocrine 1

Interventions

Leucovorin 22Fluorouracil 22Gemcitabine 21Capecitabine 21Paclitaxel 20Docetaxel 20Irinotecan 15Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × IFL protocol × Clear all
NCT00313872 2012-01-12

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

Samsung Medical Center

Phase 3 Completed
200 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT00374036 2011-10-12

Metastatic Gastric Cancer FFCD 03-07

University Hospital, Toulouse

Phase 3 Completed
416 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡